PE/Cyanine7 Anti-Human CD11b Antibody[ICRF44]

PE/Cyanine7 Anti-Human CD11b Antibody[ICRF44]

Introducing the PE/Cyanine7 Anti-Human CD11b Antibody [ICRF44], a highly advanced and meticulously developed product designed to cater to the needs of scientific research and diagnostic applications. This antibody, with its exceptional specificity and affinity towards the CD11b antigen, offers an invaluable tool for the identification and analysis of human CD11b-expressing cells.

Crafted with utmost precision, the PE/Cyanine7 Anti-Human CD11b Antibody [ICRF44] exhibits remarkable performance characteristics, ensuring accurate and reliable results. Its conjugation with PE/Cyanine7 dye further enhances its utility by enabling multi-color flow cytometry experiments, facilitating the simultaneous detection of multiple targets.

This antibody's exceptional binding affinity to CD11b, a cell surface glycoprotein predominantly expressed on monocytes, macrophages, and granulocytes, enables the discrimination and enumeration of these cell populations with unparalleled accuracy. Its application extends to various research areas, including immunology, inflammation, and cancer biology, where the identification and characterization of CD11b-expressing cells play a pivotal role.

The PE/Cyanine7 Anti-Human CD11b Antibody [ICRF44] is manufactured under stringent quality control measures, ensuring batch-to-batch consistency and reproducibility. Its formulation guarantees stability and longevity, allowing for prolonged storage without compromising its performance. Furthermore, this antibody is provided in a user-friendly format, facilitating ease of use and minimizing experimental variability.

In summary, the PE/Cyanine7 Anti-Human CD11b Antibody [ICRF44] stands as an indispensable tool for researchers and diagnosticians alike, offering unparalleled specificity, reliability, and versatility. With its exceptional performance characteristics and broad applicability, this antibody is poised to revolutionize the field of cellular analysis and contribute significantly to advancements in biomedical research and clinical diagnostics.